And here’s yet another excuse for you to give to the next officer who pulls you over and finds the blunt in your ashtray.
“Dude, it’s for my prostate man! I swear!”
That’s right, scientist say chemicals in cannabis have been found to stop prostate cancer cells from growing in the laboratory, suggesting that cannabis-based medicines could one day help fight the disease.
After working initially with human cancer cell lines, scientist Ines Diaz-Laviada and her colleagues from the University of Alcala in Madrid also tested one compound on mice and discovered it produced a significant reduction in tumor growth.
Their research, published in the British Journal of Cancer, a growing trend toward medical research to investigate an active chemical called cannabinoid, which are found in marijuana. Experts stress that the research is still exploratory and many more years of testing would be needed to work out how to apply the findings to the treatment of cancer in humans.
The cannabinoids tested by the Spanish team are thought to work against prostate cancer because they block a receptor, or molecular doorway, on the surface of tumor cells. This stops them from dividing. GW has already developed an under-the-tongue spray called Sativex for the relief of some of the symptoms of multiple sclerosis, which it plans to market in Europe with Bayer and Almirall.
Researchers went on to say men will absolutely not be able to fight prostate cancer by smoking weed, but said nothing at all regarding whether ingesting it would have any positive results.
The report went on to say prior attempts at exploiting the cannibinoid system have met with mixed success. A Spanish pharmaceutical company was forced to withdraw its weight-loss drug Acomplia from the market last year because of links to mental disorders.